These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 22890513

  • 21. Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome.
    Dehoux L, Hogan J, Dossier C, Fila M, Niel O, Maisin A, Macher MA, Kwon T, Baudouin V, Deschênes G.
    Pediatr Nephrol; 2016 Nov; 31(11):2095-101. PubMed ID: 27263020
    [Abstract] [Full Text] [Related]

  • 22. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
    Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
    [Abstract] [Full Text] [Related]

  • 23. Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab.
    Fujinaga S, Someya T, Watanabe T, Ito A, Ohtomo Y, Shimizu T, Kaneko K.
    Eur J Pediatr; 2013 Apr; 172(4):513-8. PubMed ID: 23271494
    [Abstract] [Full Text] [Related]

  • 24. Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome.
    Iijima K, Sako M, Oba M, Tanaka S, Hamada R, Sakai T, Ohwada Y, Ninchoji T, Yamamura T, Machida H, Shima Y, Tanaka R, Kaito H, Araki Y, Morohashi T, Kumagai N, Gotoh Y, Ikezumi Y, Kubota T, Kamei K, Fujita N, Ohtsuka Y, Okamoto T, Yamada T, Tanaka E, Shimizu M, Horinochi T, Konishi A, Omori T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Nozu K, Japanese Study Group of Kidney Disease in Children.
    J Am Soc Nephrol; 2022 Feb; 33(2):401-419. PubMed ID: 34880074
    [Abstract] [Full Text] [Related]

  • 25. Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome.
    Novak I, Frank R, Vento S, Vergara M, Gauthier B, Trachtman H.
    Pediatr Nephrol; 2005 Sep; 20(9):1265-8. PubMed ID: 15942779
    [Abstract] [Full Text] [Related]

  • 26. Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions.
    Moudgil A, Bagga A, Jordan SC.
    Pediatr Nephrol; 2005 Oct; 20(10):1376-81. PubMed ID: 15977023
    [Abstract] [Full Text] [Related]

  • 27. Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome.
    Ito S, Kamei K, Ogura M, Sato M, Fujimaru T, Ishikawa T, Udagawa T, Iijima K.
    Pediatr Nephrol; 2011 Oct; 26(10):1823-8. PubMed ID: 21556716
    [Abstract] [Full Text] [Related]

  • 28. A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome.
    Fujinaga S, Ohtomo Y, Umino D, Takemoto M, Shimizu T, Yamashiro Y, Kaneko K.
    Pediatr Nephrol; 2007 Jan; 22(1):71-6. PubMed ID: 17086405
    [Abstract] [Full Text] [Related]

  • 29. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J, Ehrich JH, Querfeld U.
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [Abstract] [Full Text] [Related]

  • 30. Mycophenolate mofetil for sustained remission in nephrotic syndrome.
    Querfeld U, Weber LT.
    Pediatr Nephrol; 2018 Dec; 33(12):2253-2265. PubMed ID: 29750317
    [Abstract] [Full Text] [Related]

  • 31. Mycophenolate mofetil treatment in primary glomerular disease: one-year follow-up in steroid dependent and resistant nephrotic syndrome.
    Tasanarong A, Thitiarchakul S.
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S218-27. PubMed ID: 17044475
    [Abstract] [Full Text] [Related]

  • 32. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.
    Höcker B, John U, Plank C, Wühl E, Weber LT, Misselwitz J, Rascher W, Mehls O, Tönshoff B.
    Transplantation; 2004 Jul 27; 78(2):228-34. PubMed ID: 15280683
    [Abstract] [Full Text] [Related]

  • 33. Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan.
    Moorani KN, Hotchandani HM, Zubair AM, Lohana NC, Veerwani NR.
    BMC Nephrol; 2019 Jul 03; 20(1):239. PubMed ID: 31269922
    [Abstract] [Full Text] [Related]

  • 34. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
    Okada M, Sugimoto K, Yagi K, Yanagida H, Tabata N, Takemura T.
    Pediatr Int; 2007 Dec 03; 49(6):933-7. PubMed ID: 18045300
    [Abstract] [Full Text] [Related]

  • 35. Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil.
    Chandra M, Susin M, Abitbol C.
    Pediatr Nephrol; 2000 Mar 03; 14(3):224-6. PubMed ID: 10752763
    [Abstract] [Full Text] [Related]

  • 36. Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group.
    Hogg RJ, Fitzgibbons L, Bruick J, Bunke M, Ault B, Baqi N, Trachtman H, Swinford R.
    Clin J Am Soc Nephrol; 2006 Nov 03; 1(6):1173-8. PubMed ID: 17699344
    [Abstract] [Full Text] [Related]

  • 37. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
    Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
    Nephrology (Carlton); 2015 Jan 03; 20(1):18-24. PubMed ID: 25312783
    [Abstract] [Full Text] [Related]

  • 38. Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome.
    Fujinaga S, Sakuraya K, Yamada A, Urushihara Y, Ohtomo Y, Shimizu T.
    Pediatr Nephrol; 2015 Apr 03; 30(4):687-91. PubMed ID: 25576066
    [Abstract] [Full Text] [Related]

  • 39. Mycophenolate Mofetil as a Rescue Therapy in Frequently Relapsing/Steroid-Dependent Nephrotic Syndrome in Children; Ability to Maintain Remission.
    Seyedzadeh A, Tohidi MR, Rafati M, Seyedzadeh MS, Hookari S.
    Iran J Kidney Dis; 2021 Sep 03; 15(5):364-372. PubMed ID: 34582371
    [Abstract] [Full Text] [Related]

  • 40. [Mycophenolate mofetil restores renal function and spares steroids during idiopathic nephrotic syndrome in children. A cohort study].
    Cailliez M, Bruno D, Daniel L, Afaneti M, Bérard E, Sarles J, Tsimaratos M.
    Nephrol Ther; 2008 Feb 03; 4(1):15-20. PubMed ID: 18096455
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.